Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus.,Journal of Diabetes Investigation

当前位置： X-MOL 学术 › J. Diabetes Investig. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus.
Journal of Diabetes Investigation ( IF 3.1 ) Pub Date : 2020-03-27 , DOI: 10.1111/jdi.13224
Hui Fang ₁ , Fengmei Xu ₂ , Jin Du ₃ , Li Liang ₄ , Wei Li ₅ , Liya Shen ₆ , Xueying Wang ₇ , Chun Xu ₈ , Fang Bian ₉ , Yiming Mu ₃

Affiliation

This secondary analysis of the 24‐week SMART study examined the efficacy of add‐on saxagliptin or acarbose to metformin across different patient subgroups with type 2 diabetes mellitus, based on baseline characteristics.

更新日期：2020-03-27

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11